Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TRL-345 by Trellis Bioscience for Cytomegalovirus (HHV-5) Infections: Likelihood of Approval
TRL-345 is under clinical development by Trellis Bioscience and currently in Phase I for Cytomegalovirus (HHV-5) Infections. According to GlobalData,...